Ammonia and ethylene biomarkers in the respiration of the people with schizophrenia using photoacoustic spectroscopy

Abstract. Oxidative stress has become an exciting area of schizophrenia (SCZ) research, and provides ample opportunities and hope for a better understanding of its pathophysiology, which may lead to new treatment strategies. The first objective of the present study was to analyze the oxidative stress markers in breath samples of patients with SCZ before and after the treatment with Levomepromazine. The second objective was to analyze the deficiency of amino acids marker in breath samples of patients with SCZ before and after the treatment. Exhaled breath was collected from 15 SCZ patients and 19 healthy controls; subsequently, CO2 laser photoacoustic spectroscopy was used to assess the exhaled breath compounds of the study subjects. One of the main breath biomarkers of the oxidative stress is ethylene, while one of the main breath biomarkers of the amino acids deficiency is ammonia. The breath biomarkers in the exhalation of SCZ patients exhibited significant differences from the breath biomarkers in the exhalation of healthy controls. Analysis of breath ethylene and breath ammonia provides a related model of SCZ exhalation that could represent an effective and convenient screening method for this intellectual disability.

[1]  Cristina Popa,et al.  Testing fruit quality by photoacoustic spectroscopy assay , 2014 .

[2]  Fengmin Zhang,et al.  Noninvasive detection of colorectal cancer by analysis of exhaled breath , 2014, Analytical and Bioanalytical Chemistry.

[3]  Alin Ciobica,et al.  Oxidative stress in schizophrenia - focusing on the main markers. , 2011, Psychiatria Danubina.

[4]  Andrew Mooney,et al.  Palliative and end-of-life care in advanced renal failure. , 2010, Clinical medicine.

[5]  Michael Berk,et al.  Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. , 2009, Annals of the Academy of Medicine, Singapore.

[6]  Xiang Yang Zhang,et al.  The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial , 2006, Psychopharmacology.

[7]  C. Fendri,et al.  Implication du stress oxydant dans la physiopathologie de la schizophrénie: revue de la littérature. , 2006 .

[8]  S A Cohen,et al.  Risperidone for Aggression and Self-Injurious Behavior in Adults with Mental Retardation , 1998, Journal of autism and developmental disorders.

[9]  Huseyin Vural,et al.  Is the Arginine-Nitric Oxide Pathway Involved in the Pathogenesis of Schizophrenia? , 2003, Neuropsychobiology.

[10]  Sandhya Mishra,et al.  Evaluation of antioxidant deficit in schizophrenia , 2008, Indian journal of psychiatry.

[11]  Karl Crowley,et al.  Direct measurement of ammonia in simulated human breath using an inkjet-printed polyaniline nanoparticle sensor. , 2013, Analytica chimica acta.

[12]  A Bach,et al.  Nitrogen metabolism in the rumen. , 2005, Journal of dairy science.

[13]  B. Chérif-Zahar,et al.  NH3 is involved in the NH4+ transport induced by the functional expression of the human Rh C glycoprotein. , 2004, The Journal of biological chemistry.

[14]  Joachim D Pleil,et al.  Breath analysis--past, present and future: a special issue in honour of Michael Phillips' 70th birthday. , 2013, Journal of breath research.

[15]  A. Puiu,et al.  Stress monitoring in a Guinness 10-day scuba dive , 2007 .

[16]  Brian M. Ross,et al.  Increased breath ethane and pentane concentrations in currently unmedicated patients with schizophrenia , 2011 .

[17]  Ramona Cernat,et al.  Ultrasensitive CO2 laser photoacoustic system , 2010 .

[18]  J. C. Tilak,et al.  Free radicals and antioxidants in human health: current status and future prospects. , 2004, The Journal of the Association of Physicians of India.

[19]  Cristina POPA,et al.  SPECTROSCOPIC STUDIES OF ETHYLENE AND AMMONIA AS BIOMARKERS AT PATIENTS WITH DIFFERENT MEDICAL DISORDERS , 2011 .

[20]  Ganesh Dakhale,et al.  Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics , 2004, Neuropsychobiology.

[21]  Simon Gibbons,et al.  Use of Levomepromazine in the Management of Aggression in Adults with Intellectual Disability , 2008 .

[22]  L. J. Barnhill,et al.  Risperidone and Explosive Aggressive Autism , 1997, Journal of autism and developmental disorders.

[23]  Cristina Popa,et al.  Exertion in Kangoo Jumps Aerobic: Evaluation and Interpretation Using Spectroscopic Technique Determinations , 2013 .

[24]  I. Altuntaş,et al.  Erythrocyte Superoxide Dismutase and Glutathione Peroxidase Activities, and Malondialdehyde and Reduced Glutathione Levels in Schizophrenic Patients , 2000, Clinical chemistry and laboratory medicine.

[25]  Andrew M Ellis,et al.  Real-time multi-marker measurement of organic compounds in human breath: towards fingerprinting breath , 2013, Journal of breath research.

[26]  Natalia Sidorova,et al.  Smart technologies for long-term stress monitoring at work , 2013, Proceedings of the 26th IEEE International Symposium on Computer-Based Medical Systems.

[27]  Pete Smith,et al.  Energy crops: current status and future prospects , 2006 .

[28]  L. Duggan,et al.  Antipsychotic medication for challenging behaviour in people with learning disability. , 2004, The Cochrane database of systematic reviews.

[29]  Ian H. Treasaden,et al.  Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia , 2010, Annals of General Psychiatry.

[30]  R. Dweik,et al.  Exhaled breath analysis: the new frontier in medical testing , 2008, Journal of breath research.

[31]  G. Chazot,et al.  Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  M. Campbell-Thompson,et al.  Expression of the ammonia transporter proteins Rh B glycoprotein and Rh C glycoprotein in the intestinal tract. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[33]  A Dietrich-Muszalska,et al.  Oxidative stress in blood platelets from schizophrenic patients , 2005, Platelets.

[34]  J. Verlander,et al.  Role of NH3 and NH4+ transporters in renal acid-base transport. , 2011, American journal of physiology. Renal physiology.

[35]  V. Parikh,et al.  Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics , 2002, Schizophrenia Research.

[36]  Benedicta D'Souza,et al.  Oxidative injury and antioxidant vitamins E and C in Schizophrenia , 2008, Indian Journal of Clinical Biochemistry.

[37]  I. Stojanovic,et al.  Oxidative stress as marker of positive symptoms in schizophrenia , 2002 .

[38]  Iztok Grabnar,et al.  Oxidative Stress in Schizophrenia , 2011, Current neuropharmacology.

[39]  R. Cernat,et al.  Evaluation of ammonia absorption coefficients by photoacoustic spectroscopy for detection of ammonia levels in human breath , 2011 .

[40]  Joachim D Pleil,et al.  Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders , 2013, Journal of breath research.

[41]  T. Woo,et al.  Oxidative stress in schizophrenia: An integrated approach , 2011, Neuroscience & Biobehavioral Reviews.

[42]  Ömer Akyol,et al.  The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  M. Phillips,et al.  Volatile organic compounds in the breath of patients with schizophrenia. , 1995, Journal of clinical pathology.

[44]  Pamela C. Champe,et al.  Lippincott's Illustrated Reviews: Biochemistry , 2005 .

[45]  A. Kerkeni,et al.  [Oxidative stress involvement in schizophrenia pathophysiology: a review]. , 2006, L'Encephale.

[46]  S R Schroeder,et al.  Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. , 2001, American journal of mental retardation : AJMR.

[47]  Hossam Haick,et al.  Breath testing: the future for digestive cancer detection , 2013, Expert review of gastroenterology & hepatology.

[48]  S. Mukherjee,et al.  Impaired antioxidant defense at the onset of psychosis , 1996, Schizophrenia Research.

[49]  Paolo Zamboni,et al.  Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options , 2009, Current neuropharmacology.

[50]  J. Thome,et al.  Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis , 2004, Journal of Neural Transmission.

[51]  P Boesiger,et al.  Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo , 2000, The European journal of neuroscience.

[52]  H. Ponssen,et al.  [Antipsychotic medication as a cause of deep hypothermia]. , 2003, Nederlands tijdschrift voor geneeskunde.

[53]  J. Knight.  Review: Free radicals, antioxidants, and the immune system. , 2000, Annals of clinical and laboratory science.

[54]  P Sivaraman,et al.  Levomepromazine for schizophrenia (Review) , 2013 .

[55]  B. Halliwell,et al.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? , 2004, British journal of pharmacology.

[56]  Gwen Kennedy,et al.  Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. , 2005, Free radical biology & medicine.

[57]  D. C. Dumitras,et al.  Laser photoacoustic spectroscopy: principles, instrumentation, and characterization , 2007 .

[58]  Benedicta D'Souza,et al.  Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients , 2004, Indian Journal of Clinical Biochemistry.

[59]  Serena J Counsell,et al.  Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans , 2008, BMC psychiatry.

[60]  H. Lal,et al.  Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[61]  August Zabernigg,et al.  First observation of a potential non-invasive breath gas biomarker for kidney function , 2013, Journal of breath research.

[62]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[63]  J. Hellings,et al.  Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures. , 2002, American journal of mental retardation : AJMR.

[64]  C. Shields,et al.  Schizophrenia: a review. , 2007, American family physician.

[65]  L. Voesenek,et al.  Sensitive intracavity photoacoustic measurements with a CO2 waveguide laser , 1990 .

[66]  A J Knight,et al.  FREE RADICALS, ANTIOXIDANTS, AND THE IMMUNE SYSTEM , 2000 .

[67]  R. Cernat,et al.  Qualitative and quantitative determination of human biomarkers by laser photoacoustic spectroscopy methods , 2011 .

[68]  H. Canatan,et al.  Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder , 2002, Cell biochemistry and function.

[69]  P. Ranjekar,et al.  Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients , 2003, Psychiatry Research.

[70]  Ante Bilić-Prcić,et al.  Levomepromazine helps to reduce sleep problems in patients with PTSD , 2004, European Psychiatry.

[71]  D. C. Dumitras,et al.  The level of ethylene biomarker in the renal failure of elderly patients analyzed by photoacoustic spectroscopy , 2013 .

[72]  Alin Ciobica,et al.  Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease , 2010, Neuroscience Letters.

[73]  Michael Berk,et al.  Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[74]  R. Cernat,et al.  Ethylene and ammonia traces measurements from the patients’ breath with renal failure via LPAS method , 2011 .

[75]  F. Tittel,et al.  Recent advances of laser-spectroscopy-based techniques for applications in breath analysis , 2007, Journal of breath research.